Quarterly report pursuant to Section 13 or 15(d)

REVENUES FROM CONTRACTS WITH CUSTOMERS - Disaggregation of net revenues (Details)

v3.24.3
REVENUES FROM CONTRACTS WITH CUSTOMERS - Disaggregation of net revenues (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
REVENUES FROM CONTRACTS WITH CUSTOMERS        
Total product revenues $ 14,629 $ 15,279 $ 42,514 $ 44,405
Qbrexza        
REVENUES FROM CONTRACTS WITH CUSTOMERS        
Total product revenues 7,583 5,865 19,435 18,038
Accutane        
REVENUES FROM CONTRACTS WITH CUSTOMERS        
Total product revenues 3,996 4,882 15,534 15,109
Amzeeq        
REVENUES FROM CONTRACTS WITH CUSTOMERS        
Total product revenues 1,542 2,336 3,503 4,904
Zilxi        
REVENUES FROM CONTRACTS WITH CUSTOMERS        
Total product revenues 558 681 1,200 1,567
Other / legacy        
REVENUES FROM CONTRACTS WITH CUSTOMERS        
Total product revenues $ 950 $ 1,515 $ 2,842 $ 4,787